EFFECTOR THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EFTR and buy or sell other stocks, ETFs, and their options commission-free!About EFTR
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).
CEOStephen T. Worland
CEOStephen T. Worland
Employees15
Employees15
HeadquartersSolana Beach, California
HeadquartersSolana Beach, California
Founded2012
Founded2012
Employees15
Employees15
EFTR Key Statistics
Market cap38.77K
Market cap38.77K
Price-Earnings ratio-12.57
Price-Earnings ratio-12.57
Dividend yield—
Dividend yield—
Average volume2.96M
Average volume2.96M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.48
52 Week high$1.48
52 Week low$0.3378
52 Week low$0.3378
Stock Snapshot
EFFECTOR THERAPEUTICS(EFTR) stock is priced at $0.00, giving the company a market capitalization of 38.77K. It carries a P/E multiple of -12.57.
On 2025-11-17, EFFECTOR THERAPEUTICS(EFTR) stock opened at —, reached a high of —, and a low of —.
EFFECTOR THERAPEUTICS(EFTR) shares are trading with a volume of 0, against a daily average of 2.96M.
During the past year, EFFECTOR THERAPEUTICS(EFTR) stock moved between $0.34 at its lowest and $1.48 at its peak.
During the past year, EFFECTOR THERAPEUTICS(EFTR) stock moved between $0.34 at its lowest and $1.48 at its peak.
People also own
Based on the portfolios of people who own EFTR. This list is generated using Robinhood data, and it’s not a recommendation.